Skip to main content

Advertisement

Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: p66Shc gene expression in peripheral blood mononuclear cells and progression of diabetic complications

Fig. 2

p66Shc gene expression in relation to future complications. a Average baseline p66Shc expression in patients with or without incident cardiovascular (CV) death or MACE during follow-up. b Incidence of CV death or MACE during follow-up in patients categorized in two groups according to the median value of baseline p66Shc expression. c Kaplan–Meier curves for CV death or MACE in patients with low versus those with high baseline p66Shc expression. df Average baseline p66Shc expression in patients with or without development of new complications (d), macroangiopathy (e), or microangiopathy (f) during follow-up. g Incidence of new macroangiopathy during follow-up in patients categorized in two groups according to the median value of baseline p66Shc expression. Scatter plots also report median and interquartile range

Back to article page